FDA to require new safety warnings for opioids

The US Food and Drug Administration (FDA) last week announced new labeling updates and safety warnings for immediate-release (IR) and extended-released/long acting (ER/LA) opioids stemming from reports about patients’ increased sensitivity to pain or greater pain with use of these medications.